½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1555814

¹Ì±¹ÀÇ ¿¬Á¶Á÷ º¹±¸ ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®(2024-2030³â) : MedSuite

Soft Tissue Repair Market Size, Share & Trends Analysis | United States | 2024-2030 | MedSuite | Includes: Breast Reconstruction Market, Hernia Repair Market, and 3 more

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: iData Research Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 306 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

2023³â ¹Ì±¹ ¿¬Á¶Á÷ º¹±¸ ½ÃÀå ±Ô¸ð´Â 30¾ï ´Þ·¯ ÀÌ»óÀ̾ú½À´Ï´Ù. ÀÌ ½ÃÀå ¿¹Ãø±â°£ÀÎ CAGRÀº 7.2%·Î ¿¹»óµÇ¸ç ¾à 50¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

¹Ì±¹ÀÇ Àα¸ ¿ªÇÐ º¯È­´Â ¿¬Á¶Á÷ ¼ö¸® ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ³ëÈ­¿Í ºñ¸¸·ü Áõ°¡´Â Å»ÀåÀ̳ª ½Å°æ ¼Õ»ó°ú °°Àº Áúº´ÀÇ À¯º´·üÀ» ³ôÀÔ´Ï´Ù. ´ç´¢º´ ȯÀÚ ¼ö´Â 2010³âºÎÅÍ 2025³â »çÀÌ¿¡ 64% ±ÞÁõÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ô´Ù°¡ 65¼¼ ÀÌ»óÀÇ ¹Ì±¹ÀÎ ºñÀ²Àº 2016³âÀÇ 15.2%¿¡¼­ 2034³â¿¡´Â 23.4%·Î »ó½ÂÇØ, ³ëÀÎ Àα¸´Â 8,000¸¸¸í °¡±îÀÌ¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

¹Ì±¹ÀÇ ¿¬Á¶Á÷ ¼ö¸® ½ÃÀå¿¡´Â 3°³ÀÇ ÁÖ¿ä ÁøÃâ±â¾÷: Becton Dickinson(BD), AbbVie, Integra LifeSciences°¡ Á¸ÀçÇÕ´Ï´Ù. Becton Dickinson(BD)Àº ±¤¹üÀ§ÇÑ Å»Àå ¼ö¸® Á¦Ç° Æ÷Æ®Æú¸®¿À, ƯÈ÷ Phasix(R) ÀçÈí¼ö°¡´ÉÇÑ ÇÕ¼º Á¦Ç° ¶óÀο¡¼­ ¿ìÀ§¸¦ Â÷ÁöÇÏ°í ÀÖ½À´Ï´Ù.

AbbVie´Â À¯¹æ Àç°Ç°ú Å»Àå ¼ö¸®°¡ ¶Ù¾î³ª¸ç ¿Ü°úÀÇ»çµé »çÀÌ¿¡¼­ AlloDerm(R)ÀÌ ÃÖ°í ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù. Integra LifeSciences´Â ½Å°æ¡¤°æ¸· ¼öº¹À¸·Î µ¹ÃâÇÏ°í 2023³â ½ÃÀåÀ» ¼±µµÇß½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¹Ì±¹ ¿¬Á¶Á÷ ¼ö¸® ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² ºÎ¹®º° µ¿Çâ, COVID-19ÀÇ ¿µÇ⠺м®, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× ÀúÇØ ¿äÀÎ, °æÀï ½ÃÀå Á¡À¯À² ºÐ¼® ¹× ½ÃÀå ÁøÃâ ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

Á¶»ç ¹æ¹ý

¹Ì±¹ ¿¬Á¶Á÷ º¹±¸ ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

  • ¼Ò°³
  • Áö¿ª ÇÁ·ÎÆÄÀÏ
  • ½ÃÀå ºÎ¹®º° ºÐ¼®

Áúº´ °³¿ä

  • ±âº»ÀûÀÎ ÇغÎÇÐ
  • Áúº´ÀÇ Ä¡·á¿Í Áø´Ü
  • ȯÀÚ Àα¸Åë°è

Á¦Ç° Æò°¡

  • ¼Ò°³
  • Á¦Ç° Æ÷Æ®Æú¸®¿À
  • ±ÔÁ¦»óÀÇ ¹®Á¦¿Í ¸®ÄÝ
  • ÀÓ»ó½ÃÇè

¹Ì±¹ ¿¬Á¶Á÷ ¼ö¸® ½ÃÀå °³¿ä

  • ¼Ò°³
  • ½ÃÀå °³¿ä¿Í Æ®·»µå ºÐ¼®
  • ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ
  • °æÀï ½ÃÀå Á¡À¯À² ºÐ¼®
  • ÇÕº´°ú Àμö
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • AbbVie
    • Artivion
    • Axogen
    • Becton Dickinson
    • Integra LifeSciences
    • Medtronic
    • MTF Biologics
    • Stryker
    • WL Gore
  • SWOT ºÐ¼®

¼ö±â °Ç¼ö

À¯¹æ Àç°Ç ½ÃÀå

Å»Àå ¼ö¸® ½ÃÀå

°æ¸· º¹±¸ ½ÃÀå

½Å°æ º¹±¸ ½ÃÀå

½ÉÀåÇ÷°ü ÆÐÄ¡ º¹±¸ ½ÃÀå

JHS 24.09.24

In 2023, the U.S. soft tissue repair market was valued at over $3 billion, and it is projected to grow at a CAGR of 7.2% over the forecast period, reaching approximately $5 billion. This comprehensive report on the U.S. soft tissue repair market covers breast reconstruction, hernia repair, dural repair, nerve repair, and cardiovascular patch repair.MARKET REPORT

COVERAGE:

Unit Sales, Average Selling Prices, Market Value & Growth Trends

Procedure Volumes

10-Year Scope (2020-2030)

Key Market Drivers & Limiters by Segment

Competitive Landscape and Market Shares by Segment

Recent Mergers & Acquisitions

Disease Overviews and Demographic Insights

Company Profiles, Product Offerings, and SWOT Analyses for Major Players

U.S. SOFT TISSUE REPAIR MARKET TRENDS:

Shifting U.S. demographics are positively influencing the soft tissue repair market. Aging and increasing obesity rates raise the prevalence of conditions like hernias and nerve damage. The number of individuals with diabetes is expected to surge by 64% between 2010 and 2025. Additionally, the percentage of Americans aged 65 and over will rise from 15.2% in 2016 to 23.4% by 2034, bringing the elderly population to nearly 80 million.U.S.

SOFT TISSUE REPAIR MARKET COMPETITION:

There are three key players in the U.S. soft tissue repair market: Becton Dickinson (BD), AbbVie, and Integra LifeSciences.Becton Dickinson (BD) dominates with its expansive hernia repair portfolio, particularly the Phasix(R) resorbable synthetic product line.

AbbVie holds a strong second position, excelling in breast reconstruction and hernia repair, with AlloDerm(R) as a top choice among surgeons.

Integra LifeSciences stands out in nerve and dural repair, where it led the market in 2023.

MARKET SEGMENTATION OVERVIEW:

Breast Reconstruction Market - Comprising allografts, xenografts, and synthetic materials.

Hernia Repair Market - Encompassing allograft, xenograft, and synthetic devices used for inguinal, ventral, and hiatal hernia repairs.

Dural Repair Market - Divided into allograft, xenograft, and synthetic material categories.

Nerve Repair Market - Includes wraps, tubes, grafts, and cap products for nerve repair.

Cardiovascular Repair Market - Consists of both cardiac and vascular patches.

RESEARCH SCOPE SUMMARY:

Geographic Focus: United States

Base Year: 2023

Forecast Period: 2024-2030

Historical Data: 2020-2022

Quantitative Data: Market Size, Shares, Forecasts, Growth Rates, Units Sold, and Average Selling Prices

Qualitative Data: Market Trends, Limiters, Competitive Analysis, SWOT, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews

Data Sources: Primary industry interviews, physician and regulatory data, hospital and import/export data

TABLE OF CONTENT

TABLE of CONTENTS

List of Figures

List of Charts

executive summary

U.S. Soft Tissue Repair Market Overview

Competitive Analysis

Market Trends

Market Developments

Procedures Included

Procedure Codes Investigated

Markets Included

Key Report Updates

Version History

research methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

impact of covid-19 on THE U.S. Soft Tissue repair Market

  • 2.1 Introduction
  • 2.2 Analysis By Market Segment
    • 2.2.1 Worst Case Scenario
    • 2.2.2 Base Case Scenario
    • 2.2.3 Best Case Scenario

Disease Overview

  • 3.1 Basic Anatomy
  • 3.2 Disease Treatment and Diagnostic
    • 3.2.1 Breast Cancer
    • 3.2.2 Cardiovascular Tissue Repair
    • 3.2.3 Dural Tears and Cerebrospinal Fluid Leakage Prevention
    • 3.2.4 Hernia
    • 3.2.5 Peripheral Vasculature Repair
    • 3.2.6 Traumas and Burns
  • 3.3 Patient Demographics
    • 3.3.1 Breast Cancer Statistics
    • 3.3.2 Cardiovascular Disease Statistics
    • 3.3.3 Hernia Repair Statistics
    • 3.3.4 Periodontitis Statistics
    • 3.3.5 Peripheral Vascular Disease (PVD) Statistics
    • 3.3.6 Traumatic and Sport-Related Injuries Statistics

Product Assessment

  • 4.1 Introduction
  • 4.2 Product Portfolios
    • 4.2.1 Breast Reconstruction Market
    • 4.2.2 Hernia Repair Market
    • 4.2.3 Dural Repair Market
    • 4.2.4 Nerve Repair Market
    • 4.2.5 Cardiovascular Repair
  • 4.3 Regulatory Issues and Recalls
    • 4.3.1 Hernia Repair
    • 4.3.2 Dural Repair
    • 4.3.3 Nerve Repair Market FDA Recalls
    • 4.3.4 Cardiovascular Repair
  • 4.4 Clinical Trials
    • 4.4.1 Breast Reconstruction
    • 4.4.2 Hernia Repair
    • 4.4.3 Dural Repair
    • 4.4.4 Nerve Repair
    • 4.4.5 Cardiovascular Repair

U.S. soft tissue repair Market Overview

  • 5.1 Introduction
  • 5.2 Market Overview & Trend Analysis
  • 5.3 Drivers and Limiters
    • 5.3.1 Market Drivers
    • 5.3.2 Market Limiters
  • 5.4 Competitive Market Share Analysis
  • 5.5 Mergers and Acquisitions
  • 5.6 Company Profiles
    • 5.6.1 AbbVie
    • 5.6.2 Artivion
    • 5.6.3 Axogen
    • 5.6.4 Becton Dickinson
    • 5.6.5 Integra LifeSciences
    • 5.6.6 Medtronic
    • 5.6.7 MTF Biologics
    • 5.6.8 Stryker
    • 5.6.9 W.L. Gore
  • 5.7 SWOT Analysis
    • 5.7.1 AbbVie
    • 5.7.2 Artivion
    • 5.7.3 Axogen
    • 5.7.4 Becton Dickinson
    • 5.7.5 Integra LifeSciences
    • 5.7.6 Medtronic
    • 5.7.7 MTF Biologics
    • 5.7.8 Stryker
    • 5.7.9 W.L. Gore

Procedure Numbers

  • 6.1 Introduction
  • 6.2 Procedures
    • 6.2.1 Breast Reconstruction Procedures
      • 6.2.1.1 Breast Reconstruction Procedures by Method
      • 6.2.1.1.1 Implant-Based Breast Reconstruction Procedures
      • 6.2.1.1.2 Autologous Breast Reconstruction Procedures
      • 6.2.1.2 Breast Reconstruction Procedures by Care Setting
    • 6.2.2 Hernia Repair Procedures
      • 6.2.2.1 Hernia Repair Procedures by Type
      • 6.2.2.2 Hernia Repair Procedures by Care Setting
      • 6.2.2.3 Hernia Repair Procedures by Robotic Assistance
    • 6.2.3 Dural Repair Procedures
    • 6.2.4 Cardiovascular Patch Repair Procedures
    • 6.2.5 Nerve Repair Procedures

Breast Reconstruction Market

  • 7.1 Introduction
  • 7.2 Market Overview
    • 7.2.1 Breast Reconstruction Market by Material Type
    • 7.2.2 Breast Reconstruction Market by Procedure Type
    • 7.2.3 Breast Reconstruction Market by Care Setting
  • 7.3 Market Analysis and Forecast
    • 7.3.1 Breast Reconstruction Market
    • 7.3.2 Allograft Breast Reconstruction Market
    • 7.3.3 Xenograft Breast Reconstruction Market
    • 7.3.4 Synthetic Breast Reconstruction Market
    • 7.3.5 Breast Reconstruction Market by Procedure Type
      • 7.3.5.1 Implant-Based Breast Reconstruction Market
      • 7.3.5.2 Autologous Breast Reconstruction Market
    • 7.3.6 Breast Reconstruction Market by Care Setting
      • 7.3.6.1 Hospital Breast Reconstruction Market
      • 7.3.6.2 Non-Hospital Breast Reconstruction Market
  • 7.4 Drivers and Limiters
    • 7.4.1 Market Drivers
    • 7.4.2 Market Limiters
  • 7.5 Competitive Market Share Analysis

Hernia Repair Market

  • 8.1 Introduction
  • 8.2 Market Overview
    • 8.2.1 Hernia Repair Market by Segment
    • 8.2.2 Hernia Repair Market by Material Type
  • 8.3 Market Analysis and Forecast
    • 8.3.1 Hernia Repair Market
    • 8.3.2 Ventral Hernia Repair Market
      • 8.3.2.1 Allograft Ventral Hernia Repair Market
      • 8.3.2.2 Xenograft Ventral Hernia Repair Market
      • 8.3.2.2.1 Reinforced Xenograft Ventral Hernia Repair Market
      • 8.3.2.2.2 Non-Reinforced Xenograft Ventral Hernia Repair Market
      • 8.3.2.3 Synthetic Ventral Hernia Repair Market
      • 8.3.2.3.1 Resorbable Synthetic Ventral Hernia Repair Market
      • 8.3.2.3.2 Non-Resorbable Synthetic Ventral Hernia Repair Market
      • 8.3.2.4 Ventral Hernia Repair Market by Care Setting
      • 8.3.2.4.1 Hospital Ventral Hernia Repair Market
      • 8.3.2.4.2 Non-Hospital Ventral Hernia Repair Market
    • 8.3.3 Inguinal Hernia Repair Market
      • 8.3.3.1 Allograft Inguinal Hernia Repair Market
      • 8.3.3.2 Xenograft Inguinal Hernia Repair Market
      • 8.3.3.3 Synthetic Inguinal Hernia Repair Market
      • 8.3.3.4 Inguinal Hernia Repair Market by Care Setting
      • 8.3.3.4.1 Hospital Inguinal Hernia Repair Market
      • 8.3.3.4.2 Non-Hospital Inguinal Hernia Repair Market
    • 8.3.4 Hiatal Hernia Repair Market
      • 8.3.4.1 Allograft Hiatal Hernia Repair Market
      • 8.3.4.2 Xenograft Hiatal Hernia Repair Market
      • 8.3.4.2.1 Reinforced Xenograft Hiatal Hernia Repair Market
      • 8.3.4.2.2 Non-Reinforced Xenograft Hiatal Hernia Repair Market
      • 8.3.4.3 Synthetic Hiatal Hernia Repair Market
      • 8.3.4.3.1 Resorbable Synthetic Hiatal Hernia Repair Market
      • 8.3.4.3.2 Non-Resorbable Synthetic Hiatal Hernia Repair Market
      • 8.3.4.4 Hiatal Hernia Repair Market by Care Setting
      • 8.3.4.4.1 Hospital Hiatal Hernia Repair Market
      • 8.3.4.4.2 Non-Hospital Hiatal Hernia Repair Market
  • 8.4 Drivers and Limiters
    • 8.4.1 Market Drivers
    • 8.4.2 Market Limiters
  • 8.5 Competitive Market Share Analysis

Dural repair Market

  • 9.1 Introduction
  • 9.2 Market Overview
    • 9.2.1 Dural Repair Market by Material Type
    • 9.2.2 Dural Repair Market by Care Setting
  • 9.3 Market Analysis and Forecast
    • 9.3.1 Dural Repair Market
    • 9.3.2 Dural Repair Market by Material Type
      • 9.3.2.1 Allograft Dural Repair Market
      • 9.3.2.2 Xenograft Dural Repair Market
      • 9.3.2.3 Synthetic Dural Repair Market
    • 9.3.3 Dural Repair Market by Care Setting
      • 9.3.3.1 Hospital Dural Repair Market
      • 9.3.3.2 Non-Hospital Dural Repair Market
  • 9.4 Drivers and Limiters
    • 9.4.1 Market Drivers
    • 9.4.2 Market Limiters
  • 9.5 Competitive Market Share Analysis

Nerve repair Market

  • 10.1 Introduction
  • 10.2 Market Overview
    • 10.2.1 Nerve Repair Market by Product Type
    • 10.2.2 Nerve Repair Market by Care Setting
  • 10.3 Market Analysis and Forecast
    • 10.3.1 Nerve Repair Market
    • 10.3.2 Nerve Repair Market by Product Type
      • 10.3.2.1 Nerve Wrap Market
      • 10.3.2.2 Nerve Graft Market
      • 10.3.2.3 Nerve Tube Market
      • 10.3.2.4 Nerve Cap Market
    • 10.3.3 Nerve Repair Market by Care Setting
      • 10.3.3.1 Hospital Nerve Repair Market
      • 10.3.3.2 Non-Hospital Nerve Repair Market
  • 10.4 Drivers and Limiters
    • 10.4.1 Market Drivers
    • 10.4.2 Market Limiters
  • 10.5 Competitive Market Share Analysis

Cardiovascular Patch repair Market

  • 11.1 Introduction
  • 11.2 Market Overview
    • 11.2.1 Cardiovascular Patch Repair Market by Material Type
    • 11.2.2 Cardiovascular Patch Repair Market by Segment
  • 11.3 Market Analysis and Forecast
    • 11.3.1 Cardiovascular Patch Repair Market
    • 11.3.2 Cardiac Patch Market
      • 11.3.2.1 Allograft Cardiac Patch Market
      • 11.3.2.2 Xenograft Cardiac Patch Market
      • 11.3.2.3 Synthetic Cardiac Patch Market
    • 11.3.3 Vascular Patch Market
      • 11.3.3.1 Xenograft Vascular Patch Market
      • 11.3.3.2 Synthetic Vascular Patch Market
  • 11.4 Drivers and Limiters
    • 11.4.1 Market Drivers
    • 11.4.2 Market Limiters
  • 11.5 Competitive Market Share Analysis

Abbreviations

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦